lisdexamfetamine dimesylate
Generic: lisdexamfetamine dimesylate capsules
Labeler: solco healthcare us,llcDrug Facts
Product Profile
Brand Name
lisdexamfetamine dimesylate
Generic Name
lisdexamfetamine dimesylate capsules
Labeler
solco healthcare us,llc
Dosage Form
CAPSULE
Routes
Active Ingredients
lisdexamfetamine dimesylate 20 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
43547-603
Product ID
43547-603_c17f13ef-4b2e-4b45-aff9-e79a2e8a7d53
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA216266
DEA Schedule
cii
Listing Expiration
2026-12-31
Marketing Start
2023-08-26
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
43547603
Hyphenated Format
43547-603
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
lisdexamfetamine dimesylate (source: ndc)
Generic Name
lisdexamfetamine dimesylate capsules (source: ndc)
Application Number
ANDA216266 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 20 mg/1
Packaging
- 100 CAPSULE in 1 BOTTLE (43547-603-10)
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "c17f13ef-4b2e-4b45-aff9-e79a2e8a7d53", "openfda": {"upc": ["0343547604103", "0343547605100", "0343547607104", "0343547603106"], "unii": ["SJT761GEGS"], "rxcui": ["854830", "854834", "854838", "854842", "854846", "854850", "1593856"], "spl_set_id": ["68b10d9f-ca3e-493d-a309-45f1d7e08061"], "manufacturer_name": ["Solco Healthcare US,LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (43547-603-10)", "package_ndc": "43547-603-10", "marketing_start_date": "20230826"}], "brand_name": "Lisdexamfetamine dimesylate", "product_id": "43547-603_c17f13ef-4b2e-4b45-aff9-e79a2e8a7d53", "dosage_form": "CAPSULE", "pharm_class": ["Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]"], "product_ndc": "43547-603", "dea_schedule": "CII", "generic_name": "Lisdexamfetamine dimesylate capsules", "labeler_name": "Solco Healthcare US,LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lisdexamfetamine dimesylate", "active_ingredients": [{"name": "LISDEXAMFETAMINE DIMESYLATE", "strength": "20 mg/1"}], "application_number": "ANDA216266", "marketing_category": "ANDA", "marketing_start_date": "20230826", "listing_expiration_date": "20261231"}